In conclusion, our data demonstrated a clear association between high numbers of PD-L1+ CD49f+ CD133+ CTCs in the blood of patients after therapy and vulvar or cervical cancer recurrence. The gene discussed is ITGA6; the disease is cervical carcinoma.